Deferred Tax Assets, Operating Loss Carryforwards of Y-mAbs Therapeutics, Inc. from 31 Dec 2017 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary: Y-mAbs Therapeutics, Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 31 Dec 2017 to 31 Dec 2024.
Y-mAbs Therapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 31 Dec 2024 was $83,233,000, a 0.01% decline year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)

Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

Y-mAbs Therapeutics, Inc. Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$83,233,000	-$4,000	-0.01%	31 Dec 2024	10-K	04 Mar 2025	2024	FY
Q4 2023	$83,237,000	-$2,835,000	-3.3%	31 Dec 2023	10-K	04 Mar 2025	2024	FY
Q4 2022	$86,072,000	-$2,896,000	-3.3%	31 Dec 2022	10-K	29 Feb 2024	2023	FY
Q4 2021	$88,968,000	+$13,257,000	+18%	31 Dec 2021	10-K	30 Mar 2023	2022	FY
Q4 2020	$75,711,000	+$24,062,000	+47%	31 Dec 2020	10-K	01 Mar 2022	2021	FY
Q4 2019	$51,649,000	+$26,364,000	+104%	31 Dec 2019	10-K	01 Mar 2021	2020	FY
Q4 2018	$25,285,000	+$14,438,000	+133%	31 Dec 2018	10-K	12 Mar 2020	2019	FY
Q4 2017	$10,847,000			31 Dec 2017	10-K	22 Mar 2019	2018	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.